GGrantIndex
← Leaderboards

H. Scott Baldwin

Children'S Hospital Of Philadelphia

$17,752,388
Attributed
$21,596,938
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,097,784 · 13

By mechanism

R01$8,005,567 · 6
U01$5,532,479 · 1
P50$5,406,453 · 3
T32$4,361,952 · 2
RL1$2,791,333 · 1

Top collaborators

Others in their field

Top investigators on “Embryo

Research focus

EmbryoPhenotypeIn VivoCongenital Heart DisorderIn UteroSignal TransductionGrowthAdultAffectMorphogenesisCellsHeartBirthPathologyReceptorPlayIn VitroRegulationGene ExpressionAortic ValveDefectChildMorbidity - Disease RateOperative Surgical Procedures

Grant awards (56)

The role of Tie2 signaling in Aortic Valve Remodeling$693,128
R01 · FY2025 · HL · contact PI
The role of Tie2 signaling in Aortic Valve Remodeling$693,128
R01 · FY2024 · HL · contact PI
The Role of Tie1 in Gut and Mesenteric Lymphatic Function$420,210
R01 · FY2023 · DK · contact PI
The Role of Tie1 in Gut and Mesenteric Lymphatic Function$420,210
R01 · FY2022 · DK · contact PI
The Role of Tie1 in Gut and Mesenteric Lymphatic Function$440,978
R01 · FY2021 · DK · contact PI
Developmental Determinants of Cardiovascular Disease$349,529
T32 · FY2021 · HL · contact PI
Leveraging existing registry resources to facilitate clinical trials$741,499
U01 · FY2020 · TR
Developmental Determinants of Cardiovascular Disease$532,197
T32 · FY2020 · HL · contact PI
The Role of Tie1 in Gut and Mesenteric Lymphatic Function$467,016
R01 · FY2020 · DK · contact PI
Leveraging existing registry resources to facilitate clinical trials$1,134,804
U01 · FY2019 · TR
Developmental Determinants of Cardiovascular Disease$505,927
T32 · FY2019 · HL · contact PI
Leveraging existing registry resources to facilitate clinical trials$1,133,267
U01 · FY2018 · TR
Developmental Determinants of Cardiovascular Disease$502,321
T32 · FY2018 · HL · contact PI
Leveraging existing registry resources to facilitate clinical trials$1,202,291
U01 · FY2017 · TR
Developmental Determinants of Cardiovascular Disease$489,649
T32 · FY2017 · HL · contact PI
Tie Tek Modulation of Cardiac Development$395,000
R01 · FY2017 · HL · contact PI
Tie Tek Modulation of Cardiac Development$54,482
R01 · FY2017 · HL · contact PI
Leveraging existing registry resources to facilitate clinical trials$1,320,618
U01 · FY2016 · TR
Tie Tek Modulation of Cardiac Development$452,589
R01 · FY2016 · HL · contact PI
Tie Tek Modulation of Cardiac Development$384,150
R01 · FY2015 · HL · contact PI
Developmental Determinants of Cardiovascular Disease$146,316
T32 · FY2015 · HL · contact PI
Developmental Determinants of Cardiovascular Disease$133,016
T32 · FY2015 · HL · contact PI
Tie Tek Modulation of Cardiac Development$48,540
R01 · FY2015 · HL · contact PI
Tie Tek Modulation of Cardiac Development$382,200
R01 · FY2014 · HL · contact PI
Developmental Determinants of Cardiovascular Disease$351,912
T32 · FY2014 · HL · contact PI
Developmental Determinants of Cardiovascular Disease$424,587
T32 · FY2013 · HL · contact PI
Tie Tek Modulation of Cardiac Development$371,280
R01 · FY2013 · HL · contact PI
Developmental Determinants of Cardiovascular Disease$441,362
T32 · FY2012 · HL · contact PI
SysCODE Heart Valve Design and Engineering$583,565
RL1 · FY2011 · HL · contact PI
Developmental Determinants of Cardiovascular Disease$450,985
T32 · FY2011 · HL · contact PI
The Role of NDRG4 in Myocardial Development$383,750
R01 · FY2011 · HL · contact PI
SysCODE Heart Valve Design and Engineering$540,226
RL1 · FY2010 · HL · contact PI
The Role of NDRG4 in Myocardial Development$383,750
R01 · FY2010 · HL · contact PI
SysCODE Heart Valve Design and Engineering$59,463
RL1 · FY2010 · HL · contact PI
SysCODE Heart Valve Design and Engineering$545,438
RL1 · FY2009 · HL · contact PI
The Role of NDRG4 in Myocardial Development$383,750
R01 · FY2009 · HL · contact PI
SysCODE Heart Valve Design and Engineering$545,200
RL1 · FY2008 · HL · contact PI
The Role of NDRG4 in Myocardial Development$383,750
R01 · FY2008 · HL · contact PI
SysCODE Heart Valve Design and Engineering$517,441
RL1 · FY2007 · HL · contact PI
Role of Tie 1 in pulmonary vascular ontogeny$368,629
R01 · FY2006 · HL · contact PI
Training Program in Pediatric Cardiopulmmonary Research$34,151
T32 · FY2006 · HL · contact PI
TIE 1 &oxygen sensitive pulmonary vascular development$283,133
P50 · FY2005 · HL
Role of Tie 1 in pulmonary vascular ontogeny$151,000
R01 · FY2005 · HL
Role of Tie 1 in pulmonary vascular ontogeny$113,250
R01 · FY2004 · HL
Role of Tie 1 in pulmonary vascular ontogeny$113,250
R01 · FY2003 · HL
GENETIC BASIS OF CONOTRUNCAL MALFORMATIONS$1,542,862
P50 · FY2002 · HL
TIE 1 &oxygen sensitive pulmonary vascular development$264,076
P50 · FY2002 · HL
NFATC ROLE IN OUTFLOW TRACT DEVELOPMENT$186,685
P50 · FY2002 · HL
GENETIC BASIS OF CONOTRUNCAL MALFORMATIONS$1,505,437
P50 · FY2001 · HL
PECAM-1 AND VASCULOGENESIS AND HEART DEVELOPMENT$135,360
R01 · FY2001 · HL
PECAM-1 AND VASCULOGENESIS AND HEART DEVELOPMENT$110,924
R01 · FY2001 · HL
NFATC ROLE IN OUTFLOW TRACT DEVELOPMENT$0
P50 · FY2001 · HL
TIE 1 &oxygen sensitive pulmonary vascular development$0
P50 · FY2001 · HL
GENETIC BASIS OF CONOTRUNCAL MALFORMATIONS$1,452,547
P50 · FY2000 · HL
PECAM-1 AND VASCULOGENESIS AND HEART DEVELOPMENT$255,243
R01 · FY2000 · HL
NFATC ROLE IN OUTFLOW TRACT DEVELOPMENT$171,713
P50 · FY2000 · HL